The biotech startup's treatment uses light to destroy target cells, offering patients a way to heal with minimal damage to healthy tissue.
Biotech startup Rakuten Medical is eyeing the U.S. market for its novel idea to conquer cancer — light illumination therapy. The treatment, based on photoimmunotherapy — a combination of drug administration and illumination with red light — has long been in development as part of its Alluminox platform.
Extract — continue reading at the source.
Related stories
‘I still want to verify this’: Nobel Peace Prize winner Navi Pillay’s first reaction
AI Chatbots Often Fail To Help Users in Mental-Health Crisis
The Cornell 7 Case Demands More Than Outrage
Former Prince Andrew awarded $400,000 compensation after surrendering Windsor lease
Crazy Rich Asians TV show to reunite Constance Wu and Henry Golding
Court of Arbitration for Sport hears Senegal's appeal over AFCON title